BioSpace News Archive

There are currently no oral antibiotics specifically approved for use to treat pulmonary NTM infections. If successfully developed, SPR720 has the potential to address an important unmet need as the first oral antibiotic.

The public’s perception of the drug industry can be confusing. Recent studies take a hard look at the industry from different perspectives.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

In the last 80 years, the U.S. has become a powerhouse of science and technology, largely through concerted investment on the part of the government. In fact, that scientific investment drove the economy. But in recent years that investment has slipped, and many believe the U.S. is at risk of falling behind the rest of the world in scientific innovation, with potential repercussions for the economy.

Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, announced that half of the patients have been enrolled and started the treatment in the company’s Phase II-study with the company’s product candidate LL-37 for treatment of venous leg ulcers.

MagForce AG, a leading medical device company in the field of nanomedicine focused on oncology, published today its financial results as of and for the year ended December 31, 2018 as well as operative highlights.

Researchers at Cornell University have created a system of circulating liquid — “robot blood” — within robotic structures, to store energy and power robotic applications for sophisticated, long-duration tasks.

Lonza reports restated 2018 financials for sales, CORE EBITDA and CORE EBIT

The U.S. Food and Drug Administration (FDA)’s Circulatory System Devices Panel is in the middle of two days of presentations and meetings regarding mortality rates associated with the use of paclitaxel-coated balloons (DCBs) and paclitaxel-eluting stents (DESs). The discussions are noting missing data and conflicting analysis.

Chief Operating Officer Dan Paterson has been appointed to the role of president and will lead the company while the board of directors conducts a search for a new CEO.